Improved flow cytometric method to enumerate residual cells: Minimal linear detection limits for platelets, erythrocytes, and leukocytes

Clinical Cytometry

Volumn 50, Issue 4, 2002, Pages 231-237

  Pichler, J ^a   Printz, D ^a   Scharner, D ^a   Trbojevic, D ^a   Siekmann, J ^b   Fritsch, G ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b Baxter Bio Science   (Austria)

Author keywords

Fluorescence cytometry; Plasma; Residual cells

Indexed keywords

EDETIC ACID; EPITOPE; GLYCOPHORIN A; ANTIGEN; CD42A ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; GLYCOPHORIN; THROMBIN RECEPTOR;

ARTICLE; BLOOD CELL COUNT; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; PRIORITY JOURNAL; THROMBOCYTE; BLOOD CHEMISTRY; BLOOD SAMPLING; ERYTHROCYTE COUNT; HUMAN EXPERIMENT; NORMAL HUMAN; THROMBOCYTE COUNT; CYTOLOGY; ERYTHROCYTE MEMBRANE; HEMATOLOGY; INSTRUMENTATION; METABOLISM; METHODOLOGY; PATHOLOGY; PHENOTYPE; QUALITY CONTROL; REPRODUCIBILITY; STATISTICAL MODEL;

ANTIBODIES, MONOCLONAL; BLOOD CELL COUNT; BLOOD PLATELETS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLOW CYTOMETRY; GLYCOPHORIN; HEMATOLOGY; HUMANS; LEUKOCYTES; LINEAR MODELS; PHENOTYPE; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 0037103948     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.10125     Document Type: Article

References (34)

1. Budka U. Prions and transfusion medicine. Vox Sang 2000;78(Suppl 2):231-238.
2. Muylle L. The role of cytokines in blood transfusion reactions. Blood Rev 1995;9:77-83.
3. Sedlmayr P, Blaschitz A, Wilders-Truschnig M, Tiran A, Dohr G. Platelets contain interleukin-1 alpha and beta which are detectable on the cell surface after activation. Scand J Immunol 1995;42:209-214.
4. Jakobowicz R, Williams L, Silberman F. Immunization of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood. Vox Sang 1972;23:376-381.
5. Council of Europe Publishing. Strasbourg, France. Guide to the preparation use and quality assurance of blood components, 7th edition. 2001. p 127-132.
6. Coffe C, Coudurier N, Levy G, Pujol JP, Couteret Y, Masse M, et al. Comparative study of four new automated donor plasmapheresis systems. Plasma Ther Transfus Technol 1986;7:49-55.
7. Nydegger UE, Pflugshaupt R. Quality control of blood plasma harvested by the flat-sheet filter system Autopheresis-C. Plasma Ther Transfus Technol 1986;7:57-59.
8. Larsson S, Gulliksson H, Paunovic D. Evaluation of a whole-blood WBC-reduction filter that saves platelets: in vitro studies. Transfusion 2001;41:534-539.
9. Neumueller J, Schwartz DW, Mayr WR. Demonstration by flow cytometry of the numbers of residual white blood cells and platelets in filtered red blood cell concentrates and plasma preparations. Vox Sang 1997;73:220-229.
10. Dzik WH. Leukocyte counting during process control of leukoreduced blood components. Vox Sang 2000;78:223-226.
11. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998;34:61-70.
12. Jilma-Stohlawetz P, Marsik C, Horvath M, Siegmeth H, Hocker P, Jilma B. A new flow cytometric method for simultaneous measurement of residual platelets and RBCs in plasma: validation and application for QC. Transfusion 2001;41:87-92.
13. Chow MP, Lin JS, Lin CK, Kuo BI, Yung CH, Lyou JY, et al. HLA antigen and antibody association in platelet-alloimmunized patients. Chung Hua I Hsueh Tsa Chih (Taipei) 1993;51:329-332.
14. Novotny VM, van Doom R, Witvliet MD, Claas FH, Brand A. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood 1995;85:1736-1741.
15. Snyder EL. Transfusion reactions: state-of-the-art 1994. Vox Sang 1994;67(Suppl 3):143-146.
16. Barclay GR, Hope J, Birkett CR, Turner ML. Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry. Br J Haematol 1999;107:804-814.
17. Holada K, Mondoro TH, Muller J, Vostal JG. Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets. Br J Haematol 1998;103: 276-282.
18. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993;73:1339-1347.
19. Deslys JP, Lasmezas C, Dormont D. Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease. Lancet 1994;343:848-849.
20. Manuelidis EE, Kim JH, Mericangas JR, Manuelidis L. Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet 1985; 2:896-897.
21. Tamai Y, Kojima H, Kitajima R, Taguchi F, Ohtani Y, Kawaguchi T, et al. Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease. N Engl J Med 1992;327:649.
22. Tateishi J. Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice. Lancet 1985;2:1074.
23. Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998;38:810-816.
24. Brown P, Cervenakova L, McShane LM, Barber P, Rubenstein R, Drohan WN. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999;39:1169-1178.
25. Brown P. The risk of blood-borne Creutzfeldt-Jakob disease. Dev Biol Stand 2000;102:53-59.
26. Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985;35:1483-1486.
27. Esmonde TF, Will RG, Slattery JM, Knight R, Harries-Jones R, de Silva R, et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993; 341:205-207.
28. Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB. Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988;51:1113-1119.
29. Heye N, Hensen S, Muller N. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1994;343:298-299.
30. Kondo K, Kuroiwa Y. A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982;11:377-381.
31. Wolfowitz E, Shechter Y. More about alloimmunization by transfusion of fresh-frozen plasma. Transfusion 1984;24:544.
32. EC Scientific Committee on Medicinal Products and Medical Devices: Opinion on the risk Quantification for CJD Transmission via Substances of Human Origin. 1998. http://europa.eu.int/comm/dg24/health/sc/scmp/out12_en.pdf.
33. McBride JA, O'Hoski P, Barnes CC, Spiak C, Blajchman MA. Rhesus alloimmunization following intensive plasma exchange. Transfusion 1983;23:352-354.
34. Bontadini A, Fruet F, Tazzari PL, Lollini PL, Conte R. Comparative analysis of six different white cell-reduction filters for packed red cells. Transfusion 1994;34:531-535.